Multicenter registry for adults with spontaneous subarachnoid hemorrhage

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational multicenter registry that enrolls adults with spontaneous subarachnoid hemorrhage confirmed by CT or cerebrospinal fluid analysis. Participating centers in the Netherlands will record patient characteristics, diagnostic findings, treatments, complications, and functional outcomes. The registry will combine these data to identify which treatment strategies and clinical factors are associated with better or worse recovery. There are no experimental interventions; the project uses real-world clinical data to guide future care and research.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Spontaneous subarachnoid hemorrhage with blood in the basal cisterns and/or major fissures on non-contrast head computed tomography (CT), or xanthochromia of cerebrospinal fluid confirmed by spectrophotometric analysis.
* Eligible etiologies/patterns:

  * Aneurysmal SAH
  * SAH from other intracranial vascular malformation (e.g. AVM, dural AVF)
  * Perimesencephalic SAH
  * Non-perimesencephalic angiogram negative SAH
  * SAH from intracranial artery dissection

Exclusion Criteria:

* Traumatic, neoplastic, infection related (except mycotic aneurysms), or iatrogenic SAH
* Isolated convexity SAH

Where it's running

• Radboud University Medical Center
  Nijmegen, Gelderland, Netherlands Recruiting
• Maastricht University Medical Center+
  Maastricht, Limburg, Netherlands Recruiting
• Elisabeth-Tweesteden Hospital
  Tilburg, North Brabant, Netherlands Recruiting
• Amsterdam University Medical Center
  Amsterdam, North Holland, Netherlands Recruiting
• Isala
  Zwolle, Overijssel, Netherlands Recruiting
• University Medical Center Groningen
  Groningen, Provincie Groningen, Netherlands Recruiting

Study contacts

• Study coordinator: P.B. van Wijngaarden, MD
• Email: measure@umcutrecht.nl
• Phone: +88 755 5555

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Understanding hemorrhage subtypes in perimesencephalic SAH and basilar artery perforator aneurysms

  This study tests whether different bleeding patterns in pmSAH, including potential basilar artery perforator aneurysms, relate to patient outcomes using a patient-reported EQ-5D measure.

  Recruiting Insel Gruppe AG, University Hospital Bern · Bern · NCT07923084

• Cardiac risk test using breast cancer radiotherapy scans to guide decisions

  This study tests whether checking coronary artery calcium on planning CT scans can help patients with breast cancer make informed heart-risk decisions during radiotherapy planning.

  Recruiting UMC Utrecht · Copenhagen and 4 other locations · NCT07703033

• Cannabidiol as add-on therapy for children with refractory epilepsy (CBD-uN1que): an individualized N-of-1 series

  This trial tests whether CBD oil helps reduce seizures in children with hard-to-treat epilepsy, using a series of personalized N-of-1 comparisons against a placebo.

  Recruiting Phase 3 UMC Utrecht · Utrecht, Utrecht · NCT07668856

• Brain-Computer Interface to Control Digital Devices for People with High Cervical Spinal Cord Injury

  This study tests a fully implantable brain-computer interface to let people with high cervical spinal cord injuries control digital devices at home.

  Recruiting UMC Utrecht · Utrecht, Utrecht · NCT07640711

• Right-time self-care advice for hip and knee osteoarthritis (e-cOAch)

  This project will test whether an online program can use regular symptom and activity reports to predict and deliver the right self-care advice about physical activity, weight, or sleep for people with hip or knee osteoarthritis.

  Recruiting UMC Utrecht · Utrecht · NCT07423858

• Chemotherapy plus adaptive MR-guided radiotherapy for esophageal adenocarcinoma

  This Phase 1 trial will see if adding adaptive MR-guided radiotherapy to perioperative chemotherapy (FLOT) before surgery helps adults with resectable esophageal or gastroesophageal junction adenocarcinoma.

  Recruiting Phase 1 UMC Utrecht · Utrecht, Utrecht · NCT07359443

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.